The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Insulin Action in Brain Regulates Systemic Metabolism and Brain Function
Abstract
Insulin receptors, as well as IGF-1 receptors and their postreceptor signaling partners, are distributed throughout the brain. Insulin acts on these receptors to modulate peripheral metabolism, including regulation of appetite, reproductive function, body temperature, white fat mass, hepatic glucose output, and response to hypoglycemia. Insulin signaling also modulates neurotransmitter channel activity, brain cholesterol synthesis, and mitochondrial function. Disruption of insulin action in the brain leads to impairment of neuronal function and synaptogenesis. In addition, insulin signaling modulates phosphorylation of tau protein, an early component in the development of Alzheimer disease. Thus, alterations in insulin action in the brain can contribute to metabolic syndrome, and the development of mood disorders and neurodegenerative diseases.
Verifying this paper
8 of 9 steps done · this page updates itself — you can leave and come back
- Registry recordVerified
- Full textFetching the open-access text — a few minutes for a paper we haven’t read before
- Reference listNot fetched yet
- Reference checkNot run yet for this paper
- StatisticsNeeds the full text
- ClaimsNeeds the full text
- Cited sourcesNeeds claims to check
- Self-checkNeeds the full text
- VerificationFindings verified
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The increase in Angptl4 in the hypothalamus of ob/ob type 2 diabetic mice is most likely due to insulin resistance.
“The increase in Angplt4 in type 2 diabetes in hypothalamus of ob/ob mice is most likely due to insulin resistance, since we [37,38] and others [39,40] have shown, obesity is associated with increased inflammation and mitochondrial dysfunction at the level of the hypothalamus and both of these can contribute to an altered insulin response.”
From Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity (2015) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
The plasticity of aging: insights from long-lived mutants
Kenyon, C. (2005) · Cell · doi:10.1016/j.cell.2005.02.002 · Cited by 1,338
Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156
Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D. (1979) · Nature · doi:10.1038/282503a0 · Cited by 1,114
Dopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073
The many faces of insulin-like peptide signalling in the brain
Fernandez, A. M., & Torres-Alemán, I. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3209 · Cited by 872
Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695
Self-citationDe Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657
Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis
Taguchi, A., Wartschow, L. M., & White, M. F. (2007) · Science · doi:10.1126/science.1142179 · Cited by 523
Cholesterol metabolism in neurons and astrocytes
Pfrieger, F. W., & Ungerer, N. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.002 · Cited by 500
Endocrine regulation of ageing
Russell, S. J., & Kahn, C. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2234 · Cited by 356
Dietrich, M. O., Liu, Z.-W., & Horvath, T. L. (2013) · Cell · doi:10.1016/j.cell.2013.09.004 · Cited by 306
Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
Vadas, O., Burke, J. E., Zhang, X., Berndt, A., & Williams, R. L. (2011) · Science Signaling · doi:10.1126/scisignal.2002165 · Cited by 299
Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity
Stuart, M. J., & Baune, B. T. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.001 · Cited by 257
Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus
Kubota, N., Terauchi, Y., Tobe, K., Yano, W., Suzuki, R., Ueki, K., Takamoto, I., Satoh, H., Maki, T., Kubota, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21484 · Cited by 239
Freude, S., Hettich, M. M., Schumann, C., Stöhr, O., Koch, L., Köhler, C., Udelhoven, M., Leeser, U., Müller, M., Kubota, N., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-132043 · Cited by 218
Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis
Könner, A. C., Hess, S., Tovar, S., Mesaros, A., Sánchez-Lasheras, C., Evers, N., Verhagen, L. A. W., Brönneke, H. S., Kleinridders, A., Hampel, B., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.021 · Cited by 194
Leptin regulation of Hsp60 impacts hypothalamic insulin signaling
Kleinridders, A., Lauritzen, H. P. M. M., Ussar, S., Christensen, J. H., Mori, M. A., Bross, P., & Kahn, C. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67615 · Cited by 130
Self-citationBenedict, C., Brede, S., Schiöth, H. B., Lehnert, H., Schultes, B., Born, J., & Hallschmid, M. (2011) · Diabetes · doi:10.2337/db10-0329 · Cited by 129
IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease
Sadagurski, M., Cheng, Z., Rozzo, A., Palazzolo, I., Kelley, G. R., Dong, X., Krainc, D., & White, M. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46305 · Cited by 107
Bolo, N. R., Musen, G., Jacobson, A. M., Weinger, K., McCartney, R. L., Flores, V., Renshaw, P. F., & Simonson, D. C. (2011) · Diabetes · doi:10.2337/db11-0506 · Cited by 72
Flagged first, then by citations
Research works printed but not linked: 104
- Rask-Madsen, 2012, Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease, Arterioscler Thromb Vasc Biol, 32, 2052, 10.1161/ATVBAHA.111.241919 · DOI
- Belfiore, 2009, Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease, Endocr Rev, 30, 586, 10.1210/er.2008-0047 · DOI
- Zhao, 2004, Insulin and the insulin receptor in experimental models of learning and memory, Eur J Pharmacol, 490, 71, 10.1016/j.ejphar.2004.02.045 · DOI
- Dou, 2005, Insulin receptor signaling in long-term memory consolidation following spatial learning, Learn Mem, 12, 646, 10.1101/lm.88005 · DOI
- Brüning, 2000, Role of brain insulin receptor in control of body weight and reproduction, Science, 289, 2122, 10.1126/science.289.5487.2122 · DOI · Paper page
- Kappeler, 2008, Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism, PLoS Biol, 6, e254, 10.1371/journal.pbio.0060254 · DOI
- Heidenreich, 1986, Oligosaccharide heterogeneity of insulin receptors. Comparison of N-linked glycosylation of insulin receptors in adipocytes and brain, Endocrinology, 118, 1835, 10.1210/endo-118-5-1835 · DOI
- McElduff, 1988, A comparison of the insulin and insulin-like growth factor I receptors from rat brain and liver, Endocrinology, 122, 1933, 10.1210/endo-122-5-1933 · DOI
- Bailyes, 1997, Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting, Biochem J, 327, 209, 10.1042/bj3270209 · DOI
- Fantin, 1999, Cloning, tissue expression, and chromosomal location of the mouse insulin receptor substrate 4 gene, Endocrinology, 140, 1329, 10.1210/endo.140.3.6578 · DOI
- Numan, 1999, Discrete expression of insulin receptor substrate-4 mRNA in adult rat brain, Brain Res Mol Brain Res, 72, 97, 10.1016/S0169-328X(99)00160-6 · DOI
- Araki, 1994, Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene, Nature, 372, 186, 10.1038/372186a0 · DOI · Paper page
- Schubert, 2003, Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation, J Neurosci, 23, 7084, 10.1523/JNEUROSCI.23-18-07084.2003 · DOI · Paper page
- Sadagurski, 2013, Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis, Mol Metab, 3, 55, 10.1016/j.molmet.2013.10.004 · DOI
- Stoica, 2011, Selective pharmacogenetic inhibition of mammalian target of rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage, Proc Natl Acad Sci U S A, 108, 3791, 10.1073/pnas.1014715108 · DOI · Paper page
- Son, 2012, Neuronal autophagy and neurodegenerative diseases, Exp Mol Med, 44, 89, 10.3858/emm.2012.44.2.031 · DOI
- Salcedo-Tello, 2011, GSK3 function in the brain during development, neuronal plasticity, and neurodegeneration, Int J Alzheimers Dis, 2011, 189728, 10.4061/2011/189728 · DOI
- Schubert, 2004, Role for neuronal insulin resistance in neurodegenerative diseases, Proc Natl Acad Sci U S A, 101, 3100, 10.1073/pnas.0308724101 · DOI
- Ren, 2013, Blunted refeeding response and increased locomotor activity in mice lacking FoxO1 in synapsin-Cre-expressing neurons, Diabetes, 62, 3373, 10.2337/db13-0597 · DOI
- Kim, 2012, FOXO1 in the ventromedial hypothalamus regulates energy balance, J Clin Invest, 122, 2578, 10.1172/JCI62848 · DOI
- Adams, 2002, Molecular psychology: roles for the ERK MAP kinase cascade in memory, Annu Rev Pharmacol Toxicol, 42, 135, 10.1146/annurev.pharmtox.42.082701.145401 · DOI
- Desai, 2011, Hypothalamic neurosphere progenitor cells in low birth-weight rat newborns: neurotrophic effects of leptin and insulin, Brain Res, 1378, 29, 10.1016/j.brainres.2010.12.080 · DOI
- Margolis, 1967, Insulin in the cerebrospinal fluid, Nature, 215, 1375, 10.1038/2151375a0 · DOI · Paper page
- Woods, 2003, Insulin and the blood-brain barrier, Curr Pharm Des, 9, 795, 10.2174/1381612033455323 · DOI
- Havrankova, 1978, Identification of insulin in rat brain, Proc Natl Acad Sci U S A, 75, 5737, 10.1073/pnas.75.11.5737 · DOI
- Devaskar, 1994, Insulin gene expression and insulin synthesis in mammalian neuronal cells, J Biol Chem, 269, 8445, 10.1016/S0021-9258(17)37214-9 · DOI
- Wang, Isolation and immortalization of MIP-GFP neurons from the hypothalamus, Endocrinology
- Lin, 2004, Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes, J Clin Invest, 114, 908, 10.1172/JCI22217 · DOI · Paper page
- Mehran, 2012, Hyperinsulinemia drives diet-induced obesity independently of brain insulin production, Cell Metab, 16, 723, 10.1016/j.cmet.2012.10.019 · DOI · Paper page
- Schwartz, 2000, Central nervous system control of food intake, Nature, 404, 661, 10.1038/35007534 · DOI · Paper page
- Biessels, 2008, Cognition and diabetes: a lifespan perspective, Lancet Neurol, 7, 184, 10.1016/S1474-4422(08)70021-8 · DOI
- Antenor-Dorsey, 2013, White matter microstructural integrity in youth with type 1 diabetes, Diabetes, 62, 581, 10.2337/db12-0696 · DOI
- den Heijer, 2003, Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI, Diabetologia, 46, 1604, 10.1007/s00125-003-1235-0 · DOI
- Lyoo, 2013, Network-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus, PLoS One, 8, e71304, 10.1371/journal.pone.0071304 · DOI
- Musen, 2012, Resting-state brain functional connectivity is altered in type 2 diabetes, Diabetes, 61, 2375, 10.2337/db11-1669 · DOI
- Biessels, 1996, Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats, Diabetes, 45, 1259, 10.2337/diab.45.9.1259 · DOI
- Li, 2002, Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents, Neuroscience, 113, 607, 10.1016/S0306-4522(02)00162-8 · DOI · Paper page
- Park, 2000, Intracerebroventricular insulin enhances memory in a passive-avoidance task, Physiol Behav, 68, 509, 10.1016/S0031-9384(99)00220-6 · DOI
- Biessels, 1998, Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment, Brain Res, 800, 125, 10.1016/S0006-8993(98)00510-1 · DOI
- Klöckener, 2011, High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons, Nat Neurosci, 14, 911, 10.1038/nn.2847 · DOI
- Christie, 1999, Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus, J Neurochem, 72, 1523, 10.1046/j.1471-4159.1999.721523.x · DOI
- Skeberdis, 2001, Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis, Proc Natl Acad Sci U S A, 98, 3561, 10.1073/pnas.051634698 · DOI
- van der Heide, 2005, Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner, J Neurochem, 94, 1158, 10.1111/j.1471-4159.2005.03269.x · DOI · Paper page
- Huang, 2004, An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus, J Neurochem, 89, 217, 10.1111/j.1471-4159.2003.02307.x · DOI
- Wang, 2000, Expression of cerebellar long-term depression requires postsynaptic clathrin-mediated endocytosis, Neuron, 25, 635, 10.1016/S0896-6273(00)81066-1 · DOI
- Ge, 2010, Hippocampal long-term depression is required for the consolidation of spatial memory, Proc Natl Acad Sci U S A, 107, 16697, 10.1073/pnas.1008200107 · DOI
- Wan, 1997, Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin, Nature, 388, 686, 10.1038/41792 · DOI
- Chiu, 2008, Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo, Neuron, 58, 708, 10.1016/j.neuron.2008.04.014 · DOI · Paper page
- Lee, 2005, Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway, J Biol Chem, 280, 18543, 10.1074/jbc.M414112200 · DOI
- Unger, 1991, Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects, Prog Neurobiol, 36, 343, 10.1016/0301-0082(91)90015-S · DOI
- Heni, 2011, Insulin promotes glycogen storage and cell proliferation in primary human astrocytes, PLoS One, 6, e21594, 10.1371/journal.pone.0021594 · DOI
- Ji, 2011, Insulin increases glutamate transporter GLT1 in cultured astrocytes, Biochem Biophys Res Commun, 405, 691, 10.1016/j.bbrc.2011.01.105 · DOI
- Suzuki, 2010, Diabetes and insulin in regulation of brain cholesterol metabolism, Cell Metab, 12, 567, 10.1016/j.cmet.2010.11.006 · DOI · Paper page
- Stobart, 2013, Multifunctional role of astrocytes as gatekeepers of neuronal energy supply, Front Cell Neurosci, 7, 38, 10.3389/fncel.2013.00038 · DOI
- Bernardinelli, 2014, Astrocyte-synapse structural plasticity, Neural Plast, 2014, 232105, 10.1155/2014/232105 · DOI
- Dong, 2001, Immune function of astrocytes, Glia, 36, 180, 10.1002/glia.1107 · DOI
- Fisher, 2003, Insulin signaling is required for insulin’s direct and indirect action on hepatic glucose production, J Clin Invest, 111, 463, 10.1172/JCI16426 · DOI
- Obici, 2002, Hypothalamic insulin signaling is required for inhibition of glucose production, Nat Med, 8, 1376, 10.1038/nm1202-798 · DOI · Paper page
- Diggs-Andrews, 2010, Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia, Diabetes, 59, 2271, 10.2337/db10-0401 · DOI
- Koch, 2008, Central insulin action regulates peripheral glucose and fat metabolism in mice, J Clin Invest, 118, 2132
- Biggers, 1989, Role of brain in counterregulation of insulin-induced hypoglycemia in dogs, Diabetes, 38, 7, 10.2337/diab.38.1.7 · DOI
- Fisher, 2005, Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia, Diabetes, 54, 1447, 10.2337/diabetes.54.5.1447 · DOI
- Sanchez-Alavez, 2011, Insulin-like growth factor 1-mediated hyperthermia involves anterior hypothalamic insulin receptors, J Biol Chem, 286, 14983, 10.1074/jbc.M110.188540 · DOI
- Bamshad, 1999, CNS origins of the sympathetic nervous system outflow to brown adipose tissue, Am J Physiol, 276, R1569
- Burks, 2000, IRS-2 pathways integrate female reproduction and energy homeostasis, Nature, 407, 377, 10.1038/35030105 · DOI
- Brothers, 2010, Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor, Cell Metab, 12, 295, 10.1016/j.cmet.2010.06.010 · DOI
- Frölich, 1999, A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer’s disease, Ann N Y Acad Sci, 893, 290, 10.1111/j.1749-6632.1999.tb07839.x · DOI
- Sandyk, 1993, The relationship between diabetes mellitus and Parkinson’s disease, Int J Neurosci, 69, 125, 10.3109/00207459309003322 · DOI
- Steen, 2005, Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease—is this type 3 diabetes?, J Alzheimers Dis, 7, 63, 10.3233/JAD-2005-7107 · DOI · Paper page
- Claxton, 2013, Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease, J Alzheimers Dis, 35, 789, 10.3233/JAD-122308 · DOI · Paper page
- de la Monte, 2012, Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease, Curr Alzheimer Res, 9, 35, 10.2174/156720512799015037 · DOI
- Carro, 2002, Serum insulin-like growth factor I regulates brain amyloid-beta levels, Nat Med, 8, 1390, 10.1038/nm1202-793 · DOI
- Carro, 2006, Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis, Neurobiol Aging, 27, 1250, 10.1016/j.neurobiolaging.2005.06.015 · DOI
- Gasparini, 2001, Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling, J Neurosci, 21, 2561, 10.1523/JNEUROSCI.21-08-02561.2001 · DOI
- Stöhr, 2013, Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease, Age (Dordr), 35, 83, 10.1007/s11357-011-9333-2 · DOI
- Bomfim, 2012, An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers, J Clin Invest, 122, 1339, 10.1172/JCI57256 · DOI
- Yang, 2013, Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes, J Alzheimers Dis, 33, 329, 10.3233/JAD-2012-121294 · DOI
- Francis, 2008, Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy, Brain, 131, 3311, 10.1093/brain/awn288 · DOI
- Farris, 2003, Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo, Proc Natl Acad Sci U S A, 100, 4162, 10.1073/pnas.0230450100 · DOI
- Iwen, 2014, Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans, J Clin Endocrinol Metab, 99, E246, 10.1210/jc.2013-3169 · DOI · Paper page
- Hu, 2007, Type 2 diabetes and the risk of Parkinson’s disease, Diabetes Care, 30, 842, 10.2337/dc06-2011 · DOI · Paper page
- Tong, 2009, Brain insulin-like growth factor and neurotrophin resistance in Parkinson’s disease and dementia with Lewy bodies: potential role of manganese neurotoxicity, J Alzheimers Dis, 16, 585, 10.3233/JAD-2009-0995 · DOI
- Wang, 2014, Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice, Exp Neurol, 251, 22, 10.1016/j.expneurol.2013.11.001 · DOI
- Chung, 2011, Direct interaction of α-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease, Neurosignals, 19, 86, 10.1159/000325028 · DOI
- Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat Rev Neurol, 9, 106, 10.1038/nrneurol.2012.263 · DOI · Paper page
- Mauch, 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science, 294, 1354, 10.1126/science.294.5545.1354 · DOI · Paper page
- Suzuki, 2013, Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function, PLoS Biol, 11, e1001532, 10.1371/journal.pbio.1001532 · DOI
- Hoekstra, 2011, Mitochondrial therapeutics in Alzheimer’s disease and Parkinson’s disease, Alzheimers Res Ther, 3, 21, 10.1186/alzrt83 · DOI
- Mann, 1999, Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior, Neuropsychopharmacology, 21, 99S, 10.1016/S0893-133X(99)00040-8 · DOI
- Figlewicz, 1994, Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra, Brain Res, 644, 331, 10.1016/0006-8993(94)91698-5 · DOI
- Williams, 2007, Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine, PLoS Biol, 5, e274, 10.1371/journal.pbio.0050274 · DOI
- Fernstrom, 1971, Brain serotonin content: increase following ingestion of carbohydrate diet, Science, 174, 1023, 10.1126/science.174.4013.1023 · DOI
- Haider, 2013, Streptozotocin-induced insulin deficiency leads to development of behavioral deficits in rats, Acta Neurol Belg, 113, 35, 10.1007/s13760-012-0121-2 · DOI
- Sharma, 2010, Neurobehavioral deficits in db/db diabetic mice, Physiol Behav, 101, 381, 10.1016/j.physbeh.2010.07.002 · DOI
- Gupta, 2014, Antidepressant effects of insulin in streptozotocin induced diabetic mice: modulation of brain serotonin system, Physiol Behav, 129, 73, 10.1016/j.physbeh.2014.02.036 · DOI
- Sharma, 2012, Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice, J Psychopharmacol, 26, 724, 10.1177/0269881111434620 · DOI
- Tatar, 2001, A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function, Science, 292, 107, 10.1126/science.1057987 · DOI
- Blüher, 2003, Extended longevity in mice lacking the insulin receptor in adipose tissue, Science, 299, 572, 10.1126/science.1078223 · DOI · Paper page
- Kleinridders, 2009, MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity, Cell Metab, 10, 249, 10.1016/j.cmet.2009.08.013 · DOI · Paper page
- Salway, 2011, Higher levels of heat shock proteins in longer-lived mammals and birds, Mech Ageing Dev, 132, 287, 10.1016/j.mad.2011.06.002 · DOI
- Willcox, 2008, FOXO3A genotype is strongly associated with human longevity, Proc Natl Acad Sci U S A, 105, 13987, 10.1073/pnas.0801030105 · DOI · Paper page
- Tennant, 2013, Diabetes augments in vivo microvascular blood flow dynamics after stroke, J Neurosci, 33, 19194, 10.1523/JNEUROSCI.3513-13.2013 · DOI
- Li, 2013, Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki rats, Brain Res, 1541, 106, 10.1016/j.brainres.2013.10.021 · DOI
- Wang, 2011, Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity, Cell Metab, 13, 105, 10.1016/j.cmet.2010.12.006 · DOI · Paper page
Cited by
Sorted by citations
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Self-citationInsulin resistance in brain alters dopamine turnover and causes behavioral disorders
Kleinridders, A., Cai, W., Cappellucci, L., Ghazarian, A., Collins, W. R., Vienberg, S. G., Pothos, E. N., & Kahn, C. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500877112 · Cited by 486
Self-citationThe cell biology of systemic insulin function
Tokarz, V. L., MacDonald, P. E., & Klip, A. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201802095 · Cited by 471
“Conversely, central defects in insulin action are emerging as a potential contributor to the development of Alzheimer’s disease (Griffith et al., 2018), possibly as a result of abnormal phosphorylation of tau protein (Kleinridders et al., 2014).”
BackgroundA cellular and spatial map of the choroid plexus across brain ventricles and ages
Dani, N., Herbst, R. H., McCabe, C., Green, G. S., Kaiser, K., Head, J. P., Cui, J., Shipley, F. B., Jang, A., Dionne, D., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.003 · Cited by 388
Michailidis, M., Moraitou, D., Tata, D. A., Kalinderi, K., Papamitsou, T., & Papaliagkas, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052687 · Cited by 330
Allostasis: A brain-centered, predictive mode of physiological regulation
Schulkin, J., & Sterling, P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.07.010 · Cited by 265
Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism
Ferris, H. A., Perry, R. J., Moreira, G. V., Shulman, G. I., Horton, J. D., & Kahn, C. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620506114 · Cited by 246
Self-citationImpaired insulin action in the human brain: causes and metabolic consequences
Heni, M., Kullmann, S., Preissl, H., Fritsche, A., & Häring, H.-U. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.173 · Cited by 245
Dimitriadis, G. D., Maratou, E., Kountouri, A., Board, M., & Lambadiari, V. (2021) · Nutrients · doi:10.3390/nu13010159 · Cited by 241
Central nervous pathways of insulin action in the control of metabolism and food intake
Kullmann, S., Kleinridders, A., Small, D. M., Fritsche, A., Häring, H.-U., Preissl, H., & Heni, M. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30113-3 · Cited by 233
Self-citationBrain insulin signalling in metabolic homeostasis and disease
Scherer, T., Sakamoto, K., & Buettner, C. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00498-x · Cited by 205
Altered mitochondrial function in insulin-deficient and insulin-resistant states
Ruegsegger, G. N., Creo, A. L., Cortes, T. M., Dasari, S., & Nair, K. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120843 · Cited by 202
Zemdegs, J., Martin, H., Pintana, H., Bullich, S., Manta, S., Marqués, M. A., Moro, C., Layé, S., Ducrocq, F., Chattipakorn, N., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2904-18.2019 · Cited by 151
Abolhassani, N., Leon, J., Sheng, Z., Oka, S., Hamasaki, H., Iwaki, T., & Nakabeppu, Y. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.005 · Cited by 140
Brain insulin sensitivity is linked to adiposity and body fat distribution
Kullmann, S., Valenta, V., Wagner, R., Tschritter, O., Machann, J., Häring, H.-U., Preissl, H., Fritsche, A., & Heni, M. (2020) · Nature Communications · doi:10.1038/s41467-020-15686-y · Cited by 134
Heni, M., Wagner, R., Kullmann, S., Gancheva, S., Roden, M., Peter, A., Stefan, N., Preissl, H., Häring, H.-U., & Fritsche, A. (2017) · Diabetes · doi:10.2337/db16-1380 · Cited by 115
Postprandial glycaemic dips predict appetite and energy intake in healthy individuals
Wyatt, P., Berry, S. E., Finlayson, G., O’Driscoll, R., Hadjigeorgiou, G., Drew, D. A., Khatib, H. A., Nguyen, L. H., Linenberg, I., Chan, A. T., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00383-x · Cited by 114
“In parallel, insulin and leptin act to decrease food intake through appetite suppression and changes in energy homeostasis(12).”
BackgroundSafety of intranasal human insulin: A review
Schmid, V., Kullmann, S., Gfrörer, W., Hund, V., Hallschmid, M., Lipp, H., Häring, H., Preissl, H., Fritsche, A., & Heni, M. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13279 · Cited by 110
Yaribeygi, H., Rashidy-Pour, A., Atkin, S. L., Jamialahmadi, T., & Sahebkar, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118645 · Cited by 96
Alzheimer’s disease as type 3 diabetes: understanding the link and implications
Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98
Glucose metabolism, neural cell senescence and Alzheimer's disease
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90
Insulin Action in the Human Brain: Evidence from Neuroimaging Studies
Kullmann, S., Heni, M., Fritsche, A., & Preissl, H. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12254 · Cited by 83
Dose-Dependent Effects of Intranasal Insulin on Resting-State Brain Activity
Kullmann, S., Veit, R., Peter, A., Pohmann, R., Scheffler, K., Häring, H.-U., Fritsche, A., Preissl, H., & Heni, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01976 · Cited by 78
The neuronal insulin receptor in its environment
Gralle, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13909 · Cited by 64
Ferreira, S. T. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12959 · Cited by 59
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58
Insulin action on astrocytes: From energy homeostasis to behaviour
González‐García, I., Gruber, T., & García‐Cáceres, C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12953 · Cited by 52
Modulation of midbrain neurocircuitry by intranasal insulin
Edwin Thanarajah, S., Iglesias, S., Kuzmanovic, B., Rigoux, L., Stephan, K. E., Brüning, J. C., & Tittgemeyer, M. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.03.050 · Cited by 55
Wiss, D. A., Criscitelli, K., Gold, M., & Avena, N. (2017) · Appetite · doi:10.1016/j.appet.2016.12.019 · Cited by 53
Mitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?
Castro, J. P., Wardelmann, K., Grune, T., & Kleinridders, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00196 · Cited by 53
Self-citationKong, F., Wu, T., Dai, J., Zhai, Z., Cai, J., Zhu, Z., Xu, Y., & Sun, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205207 · Cited by 54
Therapies modulating insulin resistance in Parkinson’s disease: A cross talk
Sharma, T., Kaur, D., Grewal, A. K., & Singh, T. G. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135754 · Cited by 44
Vienberg, S. G., Kleinridders, A., Suzuki, R., & Kahn, C. R. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.003 · Cited by 33
Self-citationAnti-ghrelin antibodies in appetite suppression: Recent advances in obesity pharmacotherapy
Rotkvic, V., & Altabas, V. (2015) · ImmunoTargets and Therapy · doi:10.2147/itt.s60398 · Cited by 32
Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
Ying, M., Maruschak, N., Mansur, R., Carvalho, A., Cha, D., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130205514 · Cited by 29
Plomgaard, P., Hansen, J. S., Ingerslev, B., Clemmesen, J. O., Secher, N. H., van Hall, G., Fritsche, A., Weigert, C., Lehmann, R., Häring, H., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13615 · Cited by 16
Metadata
- Authors
- Kleinridders, A., Ferris, H. A., Cai, W., & Kahn, C. R.
- Affiliations
- Section on Integrative Physiology and Metabolism, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-06-14
- Volume
- 63
- Issue
- 7
- Pages
- 2232-2243
- ISSN
- 0012-1797
- 1939-327X
- Cited by
- 625
- References
- 22
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review